Atlas Trials

Advanced Parkinson's Disease

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Advanced Parkinson's Disease

RecordFirmDate
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease (NCT04802733)BlueRock Therapeutics2021-05-03
A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease (NCT03007888)Impax Laboratories, LLC2016-11-14
A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD) (NCT02549092)AbbVie2015-10-26
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications (NCT01960842)AbbVie2013-10-01
Clinical Study for Adaptive Deep Brain Stimulation (aDBS)Controlled by Intracerebral Activity in Parkinson's Disease (NCT02154724)Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico2013-09-01
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease (NCT01736176)AbbVie (prior sponsor, Abbott)2013-03-01
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction (NCT01536015)UCB Pharma2012-01-01
Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease (NCT01479127)AbbVie (prior sponsor, Abbott)2011-10-01
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease (NCT00660673)AbbVie2009-11-13
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects (NCT00357994)AbbVie (prior sponsor, Abbott)2009-01-01
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease (NCT00335153)AbbVie (prior sponsor, Abbott)2008-01-01

Track Advanced Parkinson's Disease automatically

Every clearance here is in the API, with alerts when new ones post.